Contaminants in heparins continue to be unfolded.
Fareed
J
J
Ahluwalia
M
M
Wahi
R
R
Ramaccioti
E
E
Hoppensteadt
D
D
Bick
R L
RL
D000707:Anaphylaxis / Q000097:blood / Q000139:chemically induced* / Q000276:immunology / Q000401:mortality; D000818:Animals; D000925:Anticoagulants / Q000009:adverse effects*; D001777:Blood Coagulation / Q000187:drug effects; D002809:Chondroitin Sulfates / Q000009:adverse effects* / Q000737:chemistry / Q000276:immunology / Q000302:isolation & purification; D004340:Drug Contamination; D056736:Drug Recalls; D019317:Evidence-Based Medicine; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D007022:Hypotension / Q000097:blood / Q000139:chemically induced* / Q000276:immunology / Q000401:mortality; D018570:Risk Assessment
D000925:Anticoagulants; D006493:Heparin; D002809:Chondroitin Sulfates